search
Back to results

Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD

Primary Purpose

Pulmonary Disease, Chronic Obstructive

Status
Not yet recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Digital pursed lip breathing intervention
Sponsored by
Manchester Metropolitan University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pulmonary Disease, Chronic Obstructive focused on measuring Pursed lip breathing, Behavioral interventions, Gamification

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Diagnosed with COPD satisfying GOLD criteria (Agusti, 2022) ; Being Chinese; Able to understand, speak, and hear; Clinically stable for at least three months prior to enrollment (Soler-Cataluna et al., 2018) ; The classification of GOLD grades for patients is mild, moderate, and severe, which means: FEV1/FVC<70%, FEV1>30%pre (Agusti, 2022) ; Participants who were mindful about the IT technology and known how to use a smartphone. Exclusion Criteria: Impaired hand function causing inability to use the application; Have disorders in pleural effusion, pulmonary malignancy, heart diseases, stroke with sequels; Patients who have oral or nasal diseases cannot complete the exercise.

Sites / Locations

  • The Affiliated Hospital of Southwest Medical University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Digital PLB intervention

Arm Description

Participants will perform the following tasks during the intervention: Register a personal account on the theory-based pursed lip breathing intervention protocol software system installed on smartphones(DT-PLB). Acquire knowledge and skills related to pursed lip breathing by watching instructional videos. Practice Pursed Lip Breathing for 10 minutes per session, three times daily for eight weeks, as per reminders and guidance provided by the software. Earn health points by completing specific actions as instructed. Optionally post individual texts on the peer forum for peer support within the DT-PLB software. Complete two outcome assessments as scheduled.

Outcomes

Primary Outcome Measures

Recruitment rate
The number of participants who participate in the study divided by the number of participants eligible for participation
Retention rate
The number of subjects who complete the study divided by the number of subjects who participate in the study
Attrition rate
The number of subjects who drop out after participation divided by the number of subjects who participate in the study
Software usage Compliance
The compliance rate is one of compliance outcomes, reflecting the level of patient engagement in the intervention. Overall compliance will be defined as the compliance averaged in all patients. Compliance rate = (actual number of participation in the intervention/planned number of sessions)x 100%. In addition, minutes-consuming recorded on the software for participants during the research will be used to complement outcome measures of compliance.
Adverse events associated with the DT-PLB intervention
In each DT-PLB session, the participants during the intervention will record whether they had any uncomfortable feelings

Secondary Outcome Measures

mMRC Dyspnea Scale
The Modified Medical Research Council (mMRC) Dyspnea Scale consists of five categories, ranging from 0 to 4, with higher scores indicating more severe breathlessness. A score of 0 indicates no breathlessness during activities, while a score of 4 suggests breathlessness.
CAT scale
COPD assessment test (CAT)is a questionnaire-based tool that is commonly used to assess the impact of chronic obstructive pulmonary disease (COPD)on a patient's health status and quality of life. It consists of eight questions that cover a range of symptoms, including cough, sputum production, breathlessness, chest tightness, and activity limitations. Each question on the CAT is scored on a scale from 0 to 5, with a maximum possible score of 40. A higher score indicates a greater degree of symptom severity and a poorer health status.
The System Usability Scale
The system usability scale (SUS)is a standardized questionnaire that is used to evaluate the usability and user experience of a wide range of products, services, and systems. It produces a score between 0 and 100, with higher scores indicating better usability and user experience. The SUS has been validated and is widely used in both industry and research settings to evaluate the usability and user experience of a wide range of systems and products, including software applications, websites, and medical devices.
Participants overall satisfaction
Participants will be required to rate their satisfaction with this software intervention, with a 10-point numeric rating scale (NRS) , where "1" represents "very dissatisfied" and "10" means "very satisfied".
Six-minute-walking test
The Six-Minute Walk Test is a commonly used measure of functional exercise
Pulmonary function index:FEV1%predicted, FEV1/FVC
FEV1%predicted stands for "forced expiratory volume in one second predicted" and is a measure of lung function. It represents the maximum amount of air that a person can forcefully exhale from their lungs in one second. FEV1%predicted is expressed as a percentage of the predicted value for someone with the same characteristics who does not have lung disease. FEV1/FVC is another measure of lung function, which represents the ratio of the amount of air that a person can forcefully exhale in one second (FEV1)to the total amount of air that they can exhale(forced vital capacity or FVC)over the course of a full exhalation. A low FEV1/FVC ratio indicates that the airways are obstructed or narrowed, which is a characteristic feature of COPD.
Health points obtained by each participant performing formulated operations
Health points are set based on consensus, obtained by operating actions on this software: Login: participants' stay on the software lasts for over one minute, they will earn one health point, with a maximum of three health points per day. Watch PLB health education video: For every minute participants stay on the video, they will earn one health point. The maximum score for a single viewing is equal to the length of the video. Accept PLB exercise task: Earning one health point upon claiming an exercise task. For every minute spent on the exercise animated videos, patients earn one health point, with a maximum of up to ten health points. Social forum: Participants can post an update in an internal forum, earning them one health point, with a maximum of three health points per day. Reward health points of consecutive accepted tasks: an additional rewarded 50 points for continuously claiming exercises tasks for 9 consecutive times.

Full Information

First Posted
September 22, 2023
Last Updated
September 30, 2023
Sponsor
Manchester Metropolitan University
search

1. Study Identification

Unique Protocol Identification Number
NCT06063733
Brief Title
Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD
Official Title
Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 30, 2023 (Anticipated)
Primary Completion Date
April 20, 2024 (Anticipated)
Study Completion Date
April 20, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Manchester Metropolitan University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The goal of this pre-post design clinical trial is to develop a digital, theory-based Pursed Lip Breathing intervention protocol software system installed on smartphones (DT-PLB) and to preliminarily evaluate its feasibility and effects in stable Chronic Obstructive Pulmonary Disease (COPD). The main objectives are: To develop a digital, theory-based Pursed Lip Breathing intervention protocol software system installed on smartphones for managing breathing exercises in stable COPD patients. To pilot the methodological procedures of the pre-post study. To determine the recruitment rate, retention rate, attrition rate, and software usage compliance during the subject recruitment and follow-up process of the pre-post study. To evaluate the perception and satisfaction of COPD patients using the DT-PLB. To preliminarily examine the effects of using the DT-PLB intervention on COPD patients, including the six-minute walking test, FEV1% predicted, FEV1/FVC, mMRC scale, COPD assessment test scale, and health points. To identify any potential adverse events associated with the implementation of DT-PLB. Participants will perform the following tasks during the intervention: Register a personal account on the DT-PLB software. Acquire knowledge and skills related to Pursed Lip Breathing by watching instructional videos. Practice Pursed Lip Breathing for 10 minutes per session, three times daily for eight weeks, as per reminders and guidance provided by the software. Earn health points by completing specific actions as instructed. Optionally post individual texts on the peer forum for peer support within the DT-PLB software. Complete two outcome assessments as scheduled.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Disease, Chronic Obstructive
Keywords
Pursed lip breathing, Behavioral interventions, Gamification

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Digital PLB intervention
Arm Type
Experimental
Arm Description
Participants will perform the following tasks during the intervention: Register a personal account on the theory-based pursed lip breathing intervention protocol software system installed on smartphones(DT-PLB). Acquire knowledge and skills related to pursed lip breathing by watching instructional videos. Practice Pursed Lip Breathing for 10 minutes per session, three times daily for eight weeks, as per reminders and guidance provided by the software. Earn health points by completing specific actions as instructed. Optionally post individual texts on the peer forum for peer support within the DT-PLB software. Complete two outcome assessments as scheduled.
Intervention Type
Other
Intervention Name(s)
Digital pursed lip breathing intervention
Intervention Description
After registration, participants will watch an educational video on the developed software, covering the definition, benefits, and techniques of pursed lip breathing. Following this, participants will engage in pursed lip breathing interventions, guided by voice and animated instructions from the software. These sessions will occur three times daily (morning, afternoon, and night) for 10 minutes each, lasting for 8 weeks. After each session, participants can choose to post texts on a peer social forum for peer support. Fellow participants can give 'comments' or 'likes'. The principal researcher will oversee texts, peer comments, removing information containing personal data, medical recommendations, and negative comments. Additionally, participants can earn health points by performing specific actions (e.g., watching the educational video and practicing pursed lip breathing) on the software, encouraging their participation in related activities.
Primary Outcome Measure Information:
Title
Recruitment rate
Description
The number of participants who participate in the study divided by the number of participants eligible for participation
Time Frame
From baseline (T1) to the completion of the 8-week intervention (T2)
Title
Retention rate
Description
The number of subjects who complete the study divided by the number of subjects who participate in the study
Time Frame
From baseline (T1) to the completion of the 8-week intervention (T2)
Title
Attrition rate
Description
The number of subjects who drop out after participation divided by the number of subjects who participate in the study
Time Frame
From baseline (T1) to the completion of the 8-week intervention (T2)
Title
Software usage Compliance
Description
The compliance rate is one of compliance outcomes, reflecting the level of patient engagement in the intervention. Overall compliance will be defined as the compliance averaged in all patients. Compliance rate = (actual number of participation in the intervention/planned number of sessions)x 100%. In addition, minutes-consuming recorded on the software for participants during the research will be used to complement outcome measures of compliance.
Time Frame
Immediately after completion of the 8-week intervention
Title
Adverse events associated with the DT-PLB intervention
Description
In each DT-PLB session, the participants during the intervention will record whether they had any uncomfortable feelings
Time Frame
Immediately after completion of the 8-week intervention
Secondary Outcome Measure Information:
Title
mMRC Dyspnea Scale
Description
The Modified Medical Research Council (mMRC) Dyspnea Scale consists of five categories, ranging from 0 to 4, with higher scores indicating more severe breathlessness. A score of 0 indicates no breathlessness during activities, while a score of 4 suggests breathlessness.
Time Frame
From baseline (T1) to the completion of the 8-week intervention (T2)
Title
CAT scale
Description
COPD assessment test (CAT)is a questionnaire-based tool that is commonly used to assess the impact of chronic obstructive pulmonary disease (COPD)on a patient's health status and quality of life. It consists of eight questions that cover a range of symptoms, including cough, sputum production, breathlessness, chest tightness, and activity limitations. Each question on the CAT is scored on a scale from 0 to 5, with a maximum possible score of 40. A higher score indicates a greater degree of symptom severity and a poorer health status.
Time Frame
From baseline (T1) to the completion of the 8-week intervention (T2)
Title
The System Usability Scale
Description
The system usability scale (SUS)is a standardized questionnaire that is used to evaluate the usability and user experience of a wide range of products, services, and systems. It produces a score between 0 and 100, with higher scores indicating better usability and user experience. The SUS has been validated and is widely used in both industry and research settings to evaluate the usability and user experience of a wide range of systems and products, including software applications, websites, and medical devices.
Time Frame
Immediately after completion of the 8-week intervention (T2)
Title
Participants overall satisfaction
Description
Participants will be required to rate their satisfaction with this software intervention, with a 10-point numeric rating scale (NRS) , where "1" represents "very dissatisfied" and "10" means "very satisfied".
Time Frame
Immediately after completion of the 8-week intervention (T2)
Title
Six-minute-walking test
Description
The Six-Minute Walk Test is a commonly used measure of functional exercise
Time Frame
From baseline (T1) to the completion of the 8-week intervention (T2)
Title
Pulmonary function index:FEV1%predicted, FEV1/FVC
Description
FEV1%predicted stands for "forced expiratory volume in one second predicted" and is a measure of lung function. It represents the maximum amount of air that a person can forcefully exhale from their lungs in one second. FEV1%predicted is expressed as a percentage of the predicted value for someone with the same characteristics who does not have lung disease. FEV1/FVC is another measure of lung function, which represents the ratio of the amount of air that a person can forcefully exhale in one second (FEV1)to the total amount of air that they can exhale(forced vital capacity or FVC)over the course of a full exhalation. A low FEV1/FVC ratio indicates that the airways are obstructed or narrowed, which is a characteristic feature of COPD.
Time Frame
From baseline (T1) to the completion of the 8-week intervention (T2)
Title
Health points obtained by each participant performing formulated operations
Description
Health points are set based on consensus, obtained by operating actions on this software: Login: participants' stay on the software lasts for over one minute, they will earn one health point, with a maximum of three health points per day. Watch PLB health education video: For every minute participants stay on the video, they will earn one health point. The maximum score for a single viewing is equal to the length of the video. Accept PLB exercise task: Earning one health point upon claiming an exercise task. For every minute spent on the exercise animated videos, patients earn one health point, with a maximum of up to ten health points. Social forum: Participants can post an update in an internal forum, earning them one health point, with a maximum of three health points per day. Reward health points of consecutive accepted tasks: an additional rewarded 50 points for continuously claiming exercises tasks for 9 consecutive times.
Time Frame
Immediately after completion of the 8-week intervention

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosed with COPD satisfying GOLD criteria (Agusti, 2022) ; Being Chinese; Able to understand, speak, and hear; Clinically stable for at least three months prior to enrollment (Soler-Cataluna et al., 2018) ; The classification of GOLD grades for patients is mild, moderate, and severe, which means: FEV1/FVC<70%, FEV1>30%pre (Agusti, 2022) ; Participants who were mindful about the IT technology and known how to use a smartphone. Exclusion Criteria: Impaired hand function causing inability to use the application; Have disorders in pleural effusion, pulmonary malignancy, heart diseases, stroke with sequels; Patients who have oral or nasal diseases cannot complete the exercise.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Houqiang Huang, Master
Phone
+8618715799162
Email
21442584@stu.mmu.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Houqiang Huang, Master
Organizational Affiliation
Manchster Metropolitan University
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Affiliated Hospital of Southwest Medical University
City
Luzhou
State/Province
Sichuan
ZIP/Postal Code
646000
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Houqiang Huang, Master
Phone
+8618715799162
Email
21442584@stu.mmu.ac.uk

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD

We'll reach out to this number within 24 hrs